The effects of maternal postnatal depression and child sex on academic performance at age 16 years: a developmental approach

Murray, Lynne; Arteche, Adriane Xavier; Fearon, Pasco; Halligan, Sarah L.; Croudace, Tim; Cooper, Peter

doi:10.1111/j.1469-7610.2010.02259.x

Cited by 173 publications

(144 citation statements)

References 34 publications

Supporting

Mentioning

128

Contrasting

Unclassified

Order By: Relevance

“…2 Maternal perinatal mental illness can affect a child's cognitive development. 3 The increasing focus on epigenetic effects also suggests that ancestral environment can affect the health of offspring, and although studies have focused on cardiovascular and metabolic disease, both secondary and primary effects on cognition might be anticipated. 4 …”

Section: Cognitive Footprint Of Ancestral Health Pregnancy and Perimentioning

confidence: 99%

Can we model a cognitive footprint of interventions and policies to help to meet the global challenge of dementia?

Rossor¹,

Knapp²

2015

The Lancet

View full text Add to dashboard Cite

Section: Cognitive Footprint Of Ancestral Health Pregnancy and Perimentioning

confidence: 99%

Can we model a cognitive footprint of interventions and policies to help to meet the global challenge of dementia?

Rossor¹,

Knapp²

2015

The Lancet

View full text Add to dashboard Cite

“…These early effects tend to persist throughout childhood. Boys of mothers who were depressed do not achieve as well at age 16 in public exams as others (Murray et al, 2010). …”

Section: Impact Of Depression Postnatallymentioning

confidence: 99%

British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017

et al. 2017

View full text Add to dashboard Cite

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, due to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.

show abstract

“…Postpartum depression adversely affects new mothers, infants, and young families. [1][2][3][4][5][6][7] Initial attempts to improve recognition of postpartum depression included programs that provided universal screening in primary care offi ces and hospitals; these efforts increased identifi cation, but outcomes were not assessed or not improved. [8][9][10][11][12][13] More recent studies of screening for postpartum depression included referral to a mental health site for evaluation and care, but none have reported improved outcomes.…”

Section: Introductionmentioning

confidence: 99%

TRIPPD: A Practice-Based Network Effectiveness Study of Postpartum Depression Screening and Management

Yawn

Dietrich²,

Wollan³

et al. 2012

The Annals of Family Medicine

128

168

View full text Add to dashboard Cite

PURPOSE Postpartum depression is common but inadequately recognized and undertreated. Continuing depressive symptoms are associated with adverse outcomes for the woman, her infant, and family. We wanted to determine the effect of a practice-based training program for screening, diagnosis, and management of depression in postpartum mothers. METHODSIn this practice-based effectiveness study, 28 practices were randomized to usual care (n = 14) or intervention (n = 14), and 2,343 women were enrolled between 5 and 12 weeks' postpartum. The intervention sites received education and tools for postpartum depression screening, diagnosis, initiation of therapy, and follow-up within their practices. Usual-care practices received a 30-minute presentation about postpartum depression. Screening information for the usual care was obtained from baseline surveys sent directly to the central site but was not available for patient care. Outcomes were based on patient-reported outcomes (level of depressive symptoms) from surveys at 6 and 12 months, plus medical record review (diagnosis and therapy initiation). RESULTSAmong the 2,343 women enrolled, 1,897 (80.1%) provided outcome information, and were included in the analysis. Overall, 654 (34.5% of 1,897) women had elevated screening scores indicative of depression, with comparable rates in the intervention and usual-care groups. Among the 654 women with elevated postpartum depression screening scores, those in the intervention practices were more likely to receive a diagnosis (P = .0006) and therapy for postpartum depression (P = .002). They also had lower depressive symptom levels at 6 (P = .07) and 12 months' (P = .001) postpartum.CONCLUSIONS Primary care-based screening, diagnosis, and management improved mother's depression outcomes at 12 months. This practical approach could be implemented widely with modest resources.

show abstract

The effects of maternal postnatal depression and child sex on academic performance at age 16 years: a developmental approach

Abstract: The adverse effects of PND on male infants' cognitive functioning may persist through development. Continuing difficulties in mother-child interactions are also important, suggesting that both early intervention and continuing monitoring of mothers with PND may be warranted.

Cited by 173 publications

References 34 publications

Can we model a cognitive footprint of interventions and policies to help to meet the global challenge of dementia?

Can we model a cognitive footprint of interventions and policies to help to meet the global challenge of dementia?

British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017

TRIPPD: A Practice-Based Network Effectiveness Study of Postpartum Depression Screening and Management

Contact Info

Product

Resources

About